Ignite Creation Date:
2025-12-24 @ 2:14 PM
Ignite Modification Date:
2025-12-25 @ 1:13 PM
Study NCT ID:
NCT02268695
Status:
COMPLETED
Last Update Posted:
2022-08-23
First Post:
2014-10-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC
Sponsor:
Groupe Oncologie Radiotherapie Tete et Cou
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GORTEC 2014-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None